These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17875818)

  • 21. Valsartan regulates the interaction of angiotensin II type 1 receptor and endothelial nitric oxide synthase via Src/PI3K/Akt signalling.
    Su KH; Tsai JY; Kou YR; Chiang AN; Hsiao SH; Wu YL; Hou HH; Pan CC; Shyue SK; Lee TS
    Cardiovasc Res; 2009 Jun; 82(3):468-75. PubMed ID: 19307231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of angiotensin II type 1 receptor-interacting molecule in normal human kidney and IgA nephropathy.
    Masuda S; Tamura K; Wakui H; Maeda A; Dejima T; Hirose T; Toyoda M; Azuma K; Ohsawa M; Kanaoka T; Yanagi M; Yoshida S; Mitsuhashi H; Matsuda M; Ishigami T; Toya Y; Suzuki D; Nagashima Y; Umemura S
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F720-31. PubMed ID: 20685825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of vascular angiotensin II type 1 receptor by thyroid hormone.
    Fukuyama K; Ichiki T; Takeda K; Tokunou T; Iino N; Masuda S; Ishibashi M; Egashira K; Shimokawa H; Hirano K; Kanaide H; Takeshita A
    Hypertension; 2003 Mar; 41(3):598-603. PubMed ID: 12623965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valsartan ameliorates ageing-induced aorta degeneration via angiotensin II type 1 receptor-mediated ERK activity.
    Shan H; Zhang S; Li X; Yu K; Zhao X; Chen X; Jin B; Bai X
    J Cell Mol Med; 2014 Jun; 18(6):1071-80. PubMed ID: 24548645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valsartan impairs angiogenesis of mesenchymal stem cells through Akt pathway.
    Cheng CI; Hsiao CC; Wu SC; Peng SY; Yip HK; Fu M; Wang FS
    Int J Cardiol; 2013 Sep; 167(6):2765-74. PubMed ID: 22805546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina.
    Kurihara T; Ozawa Y; Nagai N; Shinoda K; Noda K; Imamura Y; Tsubota K; Okano H; Oike Y; Ishida S
    Diabetes; 2008 Aug; 57(8):2191-8. PubMed ID: 18487452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of calcium-modulating cyclophilin ligand (CAML) as transducer of angiotensin II-mediated nuclear factor of activated T cells (NFAT) activation.
    Guo S; Lopez-Ilasaca M; Dzau VJ
    J Biol Chem; 2005 Apr; 280(13):12536-41. PubMed ID: 15668245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.
    Min LJ; Mogi M; Iwanami J; Li JM; Sakata A; Fujita T; Tsukuda K; Iwai M; Horiuchi M
    Cardiovasc Res; 2007 Dec; 76(3):506-16. PubMed ID: 17706954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling.
    Du N; Feng J; Hu LJ; Sun X; Sun HB; Zhao Y; Yang YP; Ren H
    Oncol Rep; 2012 Jun; 27(6):1893-903. PubMed ID: 22426690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertension.
    Wakui H; Dejima T; Tamura K; Uneda K; Azuma K; Maeda A; Ohsawa M; Kanaoka T; Azushima K; Kobayashi R; Matsuda M; Yamashita A; Umemura S
    Cardiovasc Res; 2013 Dec; 100(3):511-9. PubMed ID: 24189624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of valsartan on angiotensin II-induced plasminogen activator inhibitor-1 biosynthesis in arterial smooth muscle cells.
    Sironi L; Calvio AM; Arnaboldi L; Corsini A; Parolari A; de Gasparo M; Tremoli E; Mussoni L
    Hypertension; 2001 Mar; 37(3):961-6. PubMed ID: 11244025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient receptor potential melastatin 7 ion channels regulate magnesium homeostasis in vascular smooth muscle cells: role of angiotensin II.
    He Y; Yao G; Savoia C; Touyz RM
    Circ Res; 2005 Feb; 96(2):207-15. PubMed ID: 15591230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. β-Arrestin-biased AT1R stimulation promotes extracellular matrix synthesis in renal fibrosis.
    Wang Y; Huang J; Liu X; Niu Y; Zhao L; Yu Y; Zhou L; Lu L; Yu C
    Am J Physiol Renal Physiol; 2017 Jul; 313(1):F1-F8. PubMed ID: 28274926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TGF-β1 downregulates AT1 receptor expression via PKC-δ-mediated Sp1 dissociation from KLF4 and Smad-mediated PPAR-γ association with KLF4.
    Zhang XH; Zheng B; Gu C; Fu JR; Wen JK
    Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):1015-23. PubMed ID: 22282354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of AT1 receptor gene on activation of protein kinase Cbeta/nicotinamide adenine dinucleotide diphosphate oxidase/ERK1/2/c-fos signaling cascade mediates long-term pressor effect of angiotensin II in rostral ventrolateral medulla.
    Chan SH; Wang LL; Tseng HL; Chan JY
    J Hypertens; 2007 Sep; 25(9):1845-61. PubMed ID: 17762649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The angiotensin II type I receptor-associated protein, ATRAP, is a transmembrane protein and a modulator of angiotensin II signaling.
    Lopez-Ilasaca M; Liu X; Tamura K; Dzau VJ
    Mol Biol Cell; 2003 Dec; 14(12):5038-50. PubMed ID: 12960423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resveratrol attenuates angiotensin II-induced senescence of vascular smooth muscle cells.
    Ichiki T; Miyazaki R; Kamiharaguchi A; Hashimoto T; Matsuura H; Kitamoto S; Tokunou T; Sunagawa K
    Regul Pept; 2012 Aug; 177(1-3):35-9. PubMed ID: 22561451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac-specific activation of angiotensin II type 1 receptor-associated protein completely suppresses cardiac hypertrophy in chronic angiotensin II-infused mice.
    Wakui H; Tamura K; Tanaka Y; Matsuda M; Bai Y; Dejima T; Masuda S; Shigenaga A; Maeda A; Mogi M; Ichihara N; Kobayashi Y; Hirawa N; Ishigami T; Toya Y; Yabana M; Horiuchi M; Minamisawa S; Umemura S
    Hypertension; 2010 May; 55(5):1157-64. PubMed ID: 20231526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The physiology and pathophysiology of a novel angiotensin receptor-binding protein ATRAP/Agtrap.
    Tamura K; Wakui H; Maeda A; Dejima T; Ohsawa M; Azushima K; Kanaoka T; Haku S; Uneda K; Masuda S; Azuma K; Shigenaga A; Koide Y; Tsurumi-Ikeya Y; Matsuda M; Toya Y; Tokita Y; Yamashita A; Umemura S
    Curr Pharm Des; 2013; 19(17):3043-8. PubMed ID: 23176217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal tubule angiotensin II type 1 receptor-associated protein promotes natriuresis and inhibits salt-sensitive blood pressure elevation.
    Wakui H; Uneda K; Tamura K; Ohsawa M; Azushima K; Kobayashi R; Ohki K; Dejima T; Kanaoka T; Tsurumi-Ikeya Y; Matsuda M; Haruhara K; Nishiyama A; Yabana M; Fujikawa T; Yamashita A; Umemura S
    J Am Heart Assoc; 2015 Mar; 4(3):e001594. PubMed ID: 25792129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.